Eli Lilly opens a new legal front in its battle against compounded GLP-1s
Posted:
Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack — the drugmaker accused two of the companies of engaging in the corporate practice of medicine.
Their entry shared how they tackle communication barriers to help healthcare teams deliver more equitable maternity care. Results due on 2 Oct.
Read more here.
With the ongoing transformation of healthcare systems, the ethical imperative to ensure fairness and equity has never been more urgent. While digital innovations offer vast potential—from telemedicine to AI-assisted diagnostics—their implementation risks exacerbating inequalities unless guided by ethical principles.
Read…